Table 2.
Secondary outcomes
| Variable | iNO group | Placebo group | p Value |
|---|---|---|---|
| IVH ≥ Gr 2 | 0/14 (0%) | 2/14 (14%) | 0.48 |
| ROP > stage 2 | 1/11 (9%) | 4/12 (33%) | 0.33 |
| PDA requiring treatment | 1/14 (7%) | 4/14 (29%) | 0.14 |
| Mechanical ventilation (days)a | 8.5 (1.5, 26) | 14 (2, 29) | 0.55 |
| NIV (days)a | 20.5 (6.5, 31) | 15 (3, 23) | 0.38 |
| BPD (oxygen at 36 weeks) | 5/12 (42%) | 5/13 (38%) | 0.87 |
| Late-onset sepsis | 0/12 (0%) | 2/13 (15%) | 0.48 |
| Length of stay (days)a | 70.5 (49, 108.5) | 52 (48, 88) | 0.35 |
| Mortality | 2/14 (14%) | 1/14 (7%) | 1.0 |
aMedian (interquartile range)
NIV non-invasive ventilation (HFNC > 2 lpm, CPAP, NIPPV)